Pharma and Biotech
| Period | Price | Change | Percent Change |
|---|---|---|---|
| 1 week | 45.00p | 0.000p | n/a |
| 1 month | 45.00p | 0.000p | n/a |
| 3 months | 40.50p | +4.50p | +11.84% |
| 6 months | 53.00p | -8.00p | -15.84% |
| 1 year | 41.00p | +4.00p | +10.39% |
| Year Ending | Revenue ( m) | Pre-tax ( m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-11 | 7,890.24 | 1,677.85 | 3.93 | n/a | n/a | -6% | n/a | 0.0% |
| 31-Dec-12 | 9,289.12 | 1,909.83 | 4.33 | n/a | n/a | +10% | n/a | 0.0% |
| 31-Dec-13 | 10,490.70 | 2,093.59 | 3.82 | n/a | n/a | -12% | n/a | 0.0% |
| 31-Dec-14 | 11,206.89 | 2,109.56 | 4.15 | n/a | n/a | +9% | n/a | 0.0% |
| 31-Dec-15 | 12,965.51 | 2,337.13 | 5.06 | n/a | n/a | +22% | 1.00 | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Suspension - Beximco Pharmaceuticals PLC | 02-Jan-2026 | 07:30 | RNS |
| Delay in Results & Temporary Suspension | 19-Dec-2025 | 11:00 | RNS |
| Suspension - Beximco Pharmaceuticals PLC | 02-Jan-2026 | ShareCast |
| Delay in Results & Temporary Suspension | 19-Dec-2025 | ShareCast |
| Beximco Pharmaceuticals launches fifth generic d... | 30-Jul-2019 | ShareCast |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Price | 45.00p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 49.70p |
| 52 Week Low | 45.00p |
| Volume | 115,518 |
| Shares Issued | 100.04m |
| Market Cap | £45.02m |
| RiskGrade | 190 |
| Latest | Previous | |
|---|---|---|
| Final | Final | |
| Ex-Div | 14-Nov-17 | n/a |
| Paid | 18-Jan-18 | n/a |
| Amount | 1.25 | 0.50 |
| Time | Volume / Share Price |
| 16:27 | 4,024 @ 49.70p |
| 13:26 | 3,566 @ 49.70p |
| 13:25 | 6,599 @ 46.24p |
| 12:48 | 6,329 @ 46.02p |
| 12:32 | 10,000 @ 47.00p |
| Chair | Ahmed Sohail Fasiur Rahman |
You are here: research